■ Canadian consensus algorithm for erectile rehabilitation following prostate cancer treatment
Dean S. Elterman, Anika R. Petrella, Lauren M. Walker et al
Can Urol Assoc J. 2019 Aug; 13(8): 239–24
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737730/
■ Geographical variations in prostate cancer outcomes: a systematic review of international evidence
Paramita Dasgupta, Peter D. Baade, Joanne F. Aitken et al
Front Oncol. 2019; 9: 238.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463763/
■ A review of optimal prostate biopsy: indication and techniques
Justin Streicher, Brian Lee Meyerson, Vidhya Karivedu, Abhinav Sidana
Ther Adv Urol. 2019 Jan-Dec; 11: 1756287219870074
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713958/
■ Treatment of advanced prostate cancer: Where are we in 2019?
F S M Monteiro, A Soares, F N G de Oliveira et al
Brazilian Journal of Oncology 2019, vol 15
■ Prostate cancer ¨super-active surveillance¨ era opened by vascular targeted photodynamic therapy
Renato B Corradi, Thiago C Travassos, Leonardo O Reis
Res Rep Urol. 2019; 11: 157–163
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549684/
■ Revisiting current treatment options for stress urinary incontinence and pelvic organ prolapse: a contemporary literature review
You (Maria) Wu, Blayne Welk
Res Rep Urol 2019: vol 11: 179-188
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590839/
■ Magnetic resonance imaging-transtrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer
Sunao Shoji
Investig Clin Urol. 2019 Jan; 60(1): 4–13
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318202/
■ How accurately can prostate gland imaging measure the prostate gland volume? Results of a systematic review
David R. H. Christie, Christopher F. Sharpley
Prostate Cancer. 2019; 2019: 6932572
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420971/
■ Glycans as biomarkers in prostate cancer
Emma Scott, Jennifer Munkley
Int J Mol Sci. 2019 Mar; 20(6): 1389
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470778/
■ Lower urinary tract symptoms and prostate cancer: is PSA testing in men with symptoms wise?
J Just, F Osgun, C Knight
British Journal of General Practice 2018, vol 68 (679): 541-542
https://bjgp.org/content/68/676/541
■ Local treatment of metastatic prostate cancer: What is the evidence so far?
P L Almeida, B J Pereira
Prostate Cancer 2018, Article ID 2654572, 7 pages
https://www.hindawi.com/journals/pc/2018/2654572/
■ Localized prostate cancer: treatment options
S Brawley, R Mohan, c D Nein
Am Fam Physician 2018, vol 97 (12): 798-805
https://www.aafp.org/afp/2018/0615/p798.html
■ Recent advances in prostate cancer treatment and drug discovery
Ekaterina Nevedomskaya, Simon J. Baumgart, Bernard Haendler
Int J Mol Sci. 2018 May; 19(5): 1359
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983695/
■ Localized prostate cancer: treatment options
S Braweley, R Mohan, C D Nein
Am Fam Physician jun 2018
https://www.aafp.org/afp/2018/0615/p798.html
■ Screening for prostate cancer
R Wolff, Y J Jadotte
Am Fam Physician 2018, vol 98 (8): 537-538
https://www.aafp.org/afp/2018/1015/od1.html
■ Circulating blood miRNAs for prostate risk stratification: mirroring the underlying tumor biology with liquid biopsies
Christianne Hoey, Stanley K Liu
Res Rep Urol. 2019; 11: 29–42
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398395/
■ Clinical Preventive Service Recommendation: Prostate Cancer – PSA-Based Prostate Cancer Scrreing in Men 55-59
https://www.aafp.org/patient-care/clinical-recommendations/all/prostate-cancer.html
■ Current surgical techniques os enucleation I homium laser encucleation of the prostate
Seung-June Oh
Investig Clin Urol. 2019 Sep; 60(5): 333–342
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722407/
■ Role of androgen receptor in prostate cancer: a review
Kazutoshi Fujita, Norio Nonomura
World J Mens Health. 2019 Sep; 37(3): 288–295
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704300/
■ Profiling prostate cancer therapeutic resistance
Cameron A. Wade, Natasha Kyprianou
Int J Mol Sci. 2018 Mar; 19(3): 904.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877765/
■ Primary cryotherapy for localized or locally advanced prostate cancer
Jae Hung Jung, Michael C Risk, Robert Goldfarb, et al
Cochrane Database Syst Rev. 2018 May; 2018(5): CD005010
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494517/
■ Is there an optimal curative option in HIV-positive men with localized prostate cancer? A systematic review
John Baladakis, Marlon Perera, Damien Bolton, Nathan Lawrentschuk, Ahmed Adam
Curr Urol. 2019 Jul; 12(4): 169–176
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738179/
■ Prostate-specific antigen (PSA) and distress: – a cross-sectional nationwide survey in men with prostate cancer in Sweden
Ulrika Rönningås, Per Fransson, Maja Holm, Agneta Wennman-Larsen
BMC Urol. 2019; 19: 66.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626380/
■ Reduced risk of prostate cancer with 5alpha-reductase inhibitors
Ian Thompson, Jr., Phyllis Goodman, Catherine Tangen
J Natl Cancer Inst. 2018 Nov; 110(11): 1159–1160
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454440/
■ Radiotherapy for prostate cancer: DISCERN quality assessment of patient-oriented websites in 2018
- Janssen, F. B. Fahlbusch, L. Käsmann, D. Rades, D. Vordermark
BMC Urol. 2019; 19: 42
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537434/
■ Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers
Anika Kremer, Tobias Kremer, Glen Kristiansen, Yuri Tolkach
BMC Urol. 2019; 19: 46.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554887/
■ Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010-2015
B A Mahal, S Butler, I Franco et al
JAMA 2019, vol 321 (7): 704-706
https://jamanetwork.com/journals/jama/fullarticle/2724897
■ Identifying quality of life indicators to improve outpatient pharmacy services for prostate cancer patients: a comparison between brazilian and british experiences
H Patel, P M Aguiar, A Pessoa Jr et al
Int braz j urol 2019, vol 45 (3)
■ Second brazilian consensus on the treatment of advanced prostate cancer: a SBOC-SBU-SBRT panel Int A D Sasse, R B dos Reis, L M Nogueira et al
Int braz j urol 2019, vol 45 (3)
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000300449
■ Physical activity in relation to risk of prostate cancer: a systematic review and meta-analysis
I N Benke, M F Leitzmann, G Behrens, D Schmid
Annals of Oncology 2018, vol 29 (5): 1154-1179
https://academic.oup.com/annonc/article/29/5/1154/4904101
■ PSA and beyond: alternative prostate cancer biomarkers
Sharanjot Saini
Cell Oncol (Dordr). 2016 Apr; 39(2): 97–106
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821699/
■ National implementation on multi-parametric magnetic resonance imaging for prostate cancer detection – recommendations form a UK consensus meeting
Mrishta Brizmohun Appayya, Jim Adshead, Hashim U. Ahmed et al
BJU Int. 2018 Jul; 122(1): 13–25
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334741/
■ The association between vasectomy and prostate cancer: a systematic review and meta-analysis
Bimal Bhindi, Christopher J. D. Wallis, Madhur Nayan, et al
JAMA Intern Med. 2017 Sep; 177(9): 1273–1286
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710573/
■ The current evidence on statin use and prostate cancer prevention: are we there yet?
Mahmoud A. Alfaqih, Emma H. Allott, Robert J. Hamilton et al
Nat Rev Urol. 2017 Feb; 14(2): 107–119
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830185/
■ Use of androgen deprivation therapy with prostate brachytherapy, A systematic literature review
Mira Keyes, Gregory Merrick, Steven J. Frank et al
Brachytherapy. 2017 Mar-Apr; 16(2): 245–265
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075682/
■ Prostate cancer in gay, bisexual, and other men who have sex with men: a review
B.R. Simon Rosser, Enyinnaya Merengwa, Benjamin D. Capistrant et al
LGBT Health. 2016 Feb 1; 3(1): 32–41
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770844/
■ The very high risk prostate cancer – a contemporary update
Roy Mano, James Eastham, Ofer Yossepowitch
Prostate Cancer Prostatic Dis. 2016 Dec; 19(4): 340–348
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559730/
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Estratificação de Risco Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Data: out 2019